Connection

Co-Authors

This is a "connection" page, showing publications co-authored by PEDRO PIEDRA and VASANTHI AVADHANULA.
Connection Strength

14.188
  1. The Humoral Immune Profiles of Infants Before and After Severe Primary RSV/A and RSV/B Infection. J Infect Dis. 2026 Aug 12.
    View in: PubMed
    Score: 0.991
  2. Evolutionary dynamics of Respiratory Syncytial Virus in pre-pandemic, pandemic, and post-pandemic periods in Houston, Texas, USA. bioRxiv. 2026 Jun 17.
    View in: PubMed
    Score: 0.980
  3. Impact of Low Community Circulation of Respiratory Syncytial Virus (RSV) on Immunity Debt against RSV in Adults During the COVID-19 Pandemic. J Infect Dis. 2026 May 25.
    View in: PubMed
    Score: 0.976
  4. Longitudinal host transcriptional responses to SARS-CoV-2 infection in adults with extremely high viral load. PLoS One. 2025; 20(1):e0317033.
    View in: PubMed
    Score: 0.889
  5. Inter and intra-host diversity of RSV in hematopoietic stem cell transplant adults with normal and delayed viral clearance. Virus Evol. 2024; 10(1):vead086.
    View in: PubMed
    Score: 0.826
  6. Longitudinal host transcriptional responses to SARS-CoV-2 infection in adults with extremely high viral load. Res Sq. 2023 Jun 05.
    View in: PubMed
    Score: 0.795
  7. Longitudinal host transcriptional responses to SARS-CoV-2 infection in adults with extremely high viral load. bioRxiv. 2023 May 25.
    View in: PubMed
    Score: 0.793
  8. The Prevention of Common Respiratory Virus Epidemics in 2020-21 during the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Pandemic: An Unexpected Benefit of the Implementation of Public Health Measures. Lancet Reg Health Am. 2021 Oct; 2:100043.
    View in: PubMed
    Score: 0.702
  9. Viral Load of Severe Acute Respiratory Syndrome Coronavirus 2 in Adults During the First and Second Wave of Coronavirus Disease 2019 Pandemic in Houston, Texas: The Potential of the Superspreader. J Infect Dis. 2021 05 20; 223(9):1528-1537.
    View in: PubMed
    Score: 0.690
  10. Infection with novel respiratory syncytial virus genotype Ontario (ON1) in adult hematopoietic cell transplant recipients, Texas, 2011-2013. J Infect Dis. 2015 Feb 15; 211(4):582-9.
    View in: PubMed
    Score: 0.432
  11. RSV can infect the human nasal epithelium via the basolateral route and shows distinct subgroup infectivity and basal cell tropism. J Virol. 2026 Jul 21; 100(7):e0037426.
    View in: PubMed
    Score: 0.245
  12. Strain-Specific Variability in Viral Kinetics, Cytokine Response, and Cellular Damage in Air-Liquid Cultures of Human Nasal Organoids After Infection with SARS-CoV-2. Viruses. 2025 Oct 06; 17(10).
    View in: PubMed
    Score: 0.234
  13. Single cell sequencing analysis of respiratory syncytial virus-infected pediatric and adult human nose organoids reveals age differences, proliferative diversity and identifies novel cellular tropism. J Infect. 2025 Oct; 91(4):106617.
    View in: PubMed
    Score: 0.233
  14. Infant-derived human nasal organoids exhibit relatively increased susceptibility, epithelial responses, and cytotoxicity during RSV infection. J Infect. 2024 Dec; 89(6):106305.
    View in: PubMed
    Score: 0.218
  15. Examining intra-host genetic variation of RSV by short read high-throughput sequencing. bioRxiv. 2024 Sep 03.
    View in: PubMed
    Score: 0.217
  16. Respiratory viral detection in the plasma and cerebrospinal fluid (CSF) of young febrile infants. Influenza Other Respir Viruses. 2024 02; 18(2):e13250.
    View in: PubMed
    Score: 0.208
  17. Pediatric human nose organoids demonstrate greater susceptibility, epithelial responses, and cytotoxicity than adults during RSV infection. bioRxiv. 2024 Feb 01.
    View in: PubMed
    Score: 0.208
  18. The Efficiency of p27 Cleavage during In Vitro Respiratory Syncytial Virus (RSV) Infection Is Cell Line and RSV Subtype Dependent. J Virol. 2023 05 31; 97(5):e0025423.
    View in: PubMed
    Score: 0.197
  19. Modeling nonsegmented negative-strand RNA virus (NNSV) transcription with ejective polymerase collisions and biased diffusion. Front Mol Biosci. 2022; 9:1095193.
    View in: PubMed
    Score: 0.193
  20. Adult Memory T Cell Responses to the Respiratory Syncytial Virus Fusion Protein During a Single RSV Season (2018-2019). Front Immunol. 2022; 13:823652.
    View in: PubMed
    Score: 0.183
  21. Antibody responses of healthy adults to the p27 peptide of respiratory syncytial virus fusion protein. Vaccine. 2022 01 24; 40(3):536-543.
    View in: PubMed
    Score: 0.179
  22. Serum IgG anti-SARS-CoV-2 Binding Antibody Level Is Strongly Associated With IgA and Functional Antibody Levels in Adults Infected With SARS-CoV-2. Front Immunol. 2021; 12:693462.
    View in: PubMed
    Score: 0.177
  23. SARS-CoV-2 re-infection versus prolonged shedding: A case series. Influenza Other Respir Viruses. 2021 11; 15(6):691-696.
    View in: PubMed
    Score: 0.173
  24. Humoral and Mucosal Antibody Response to RSV Structural Proteins in RSV-Infected Adult Hematopoietic Cell Transplant (HCT) Recipients. Viruses. 2021 05 26; 13(6).
    View in: PubMed
    Score: 0.173
  25. A prospective surveillance study on the kinetics of the humoral immune response to the respiratory syncytial virus fusion protein in adults in Houston, Texas. Vaccine. 2021 02 22; 39(8):1248-1256.
    View in: PubMed
    Score: 0.169
  26. Antibody Response to the Furin Cleavable Twenty-Seven Amino Acid Peptide (p27) of the Fusion Protein in Respiratory Syncytial Virus (RSV) Infected Adult Hematopoietic Cell Transplant (HCT) Recipients. Vaccines (Basel). 2020 Apr 21; 8(2).
    View in: PubMed
    Score: 0.160
  27. The Risk of Serious Bacterial Infection in Febrile Infants 0-90 Days of Life With a Respiratory Viral Infection. Pediatr Infect Dis J. 2019 04; 38(4):355-361.
    View in: PubMed
    Score: 0.149
  28. Antigenic Site-Specific Competitive Antibody Responses to the Fusion Protein of Respiratory Syncytial Virus Were Associated With Viral Clearance in Hematopoietic Cell Transplantation Adults. Front Immunol. 2019; 10:706.
    View in: PubMed
    Score: 0.149
  29. A Cross-sectional Surveillance Study of the Frequency and Etiology of Acute Respiratory Illness Among Pregnant Women. J Infect Dis. 2018 07 13; 218(4):528-535.
    View in: PubMed
    Score: 0.141
  30. Comparison of Palivizumab-Like Antibody Binding to Different Conformations of the RSV F Protein in RSV-Infected Adult Hematopoietic Cell Transplant Recipients. J Infect Dis. 2018 03 28; 217(8):1247-1256.
    View in: PubMed
    Score: 0.139
  31. Correction: Sequence variability of the respiratory syncytial virus (RSV) fusion gene among contemporary and historical genotypes of RSV/A and RSV/B. PLoS One. 2017; 12(6):e0180623.
    View in: PubMed
    Score: 0.132
  32. Sequence variability of the respiratory syncytial virus (RSV) fusion gene among contemporary and historical genotypes of RSV/A and RSV/B. PLoS One. 2017; 12(4):e0175792.
    View in: PubMed
    Score: 0.130
  33. Lactate dehydrogenase and caspase activity in nasopharyngeal secretions are predictors of bronchiolitis severity. Influenza Other Respir Viruses. 2014 Nov; 8(6):617-25.
    View in: PubMed
    Score: 0.108
  34. Respiratory Viral Detection and Invasive Bacterial Infections in Infants =90 Days. Pediatr Infect Dis J. 2026 Aug 10.
    View in: PubMed
    Score: 0.062
  35. Maternal RSV Vaccination, Infant Nirsevimab, or Both: Interim Analysis of a Randomized Trial. Pediatrics. 2026 Jun 01; 157(6).
    View in: PubMed
    Score: 0.061
  36. Streptococcus pneumoniae colonization modulates human nasal epithelial responses to respiratory syncytial virus infection. bioRxiv. 2026 Feb 05.
    View in: PubMed
    Score: 0.060
  37. Oral dosing of the nucleoside analog obeldesivir is efficacious against RSV infection in African green monkeys. Nat Commun. 2025 Jul 11; 16(1):6437.
    View in: PubMed
    Score: 0.057
  38. Complete genomic characterization of global pathogens respiratory syntical virus and human norovirus using probe based capture enrichment. Sci Rep. 2025 Jul 01; 15(1):20526.
    View in: PubMed
    Score: 0.057
  39. Epidemiology and genotypic diversity of rhinovirus in school-age children with acute respiratory illnesses seeking medical care. J Clin Virol. 2025 Aug; 179:105806.
    View in: PubMed
    Score: 0.057
  40. Mucosal vaccines with STING-agonist liposomal formulations inhibit RSV (respiratory syncytial virus) replication in cotton rats. Vaccine. 2025 05 22; 56:127183.
    View in: PubMed
    Score: 0.057
  41. Complete Genomic Characterization of Global Pathogens, Respiratory Syncytial Virus (RSV), and Human Norovirus (HuNoV) Using Probe-based Capture Enrichment. bioRxiv. 2024 Sep 16.
    View in: PubMed
    Score: 0.054
  42. Sequencing-Based Detection of Avian Influenza A(H5N1) Virus in Wastewater in Ten Cities. N Engl J Med. 2024 09 26; 391(12):1157-1159.
    View in: PubMed
    Score: 0.054
  43. Seasonality, Clinical Characteristics, and Outcomes of Respiratory Syncytial Virus Disease by Subtype Among Children Aged <5 Years: New Vaccine Surveillance Network, United States, 2016-2020. Clin Infect Dis. 2024 05 15; 78(5):1352-1359.
    View in: PubMed
    Score: 0.053
  44. Targeted accurate RNA consensus sequencing (tARC-seq) reveals mechanisms of replication error affecting SARS-CoV-2 divergence. Nat Microbiol. 2024 May; 9(5):1382-1392.
    View in: PubMed
    Score: 0.053
  45. Design, Synthesis, X-ray Crystallography, and Biological Activities of Covalent, Non-Peptidic Inhibitors of SARS-CoV-2 Main Protease. ACS Infect Dis. 2024 02 09; 10(2):715-731.
    View in: PubMed
    Score: 0.052
  46. Wastewater sequencing reveals community and variant dynamics of the collective human virome. Nat Commun. 2023 10 28; 14(1):6878.
    View in: PubMed
    Score: 0.051
  47. Wastewater pandemic preparedness: Toward an end-to-end pathogen monitoring program. Front Public Health. 2023; 11:1137881.
    View in: PubMed
    Score: 0.049
  48. Sustained Within-season Vaccine Effectiveness Against Influenza-associated Hospitalization in Children: Evidence From the New Vaccine Surveillance Network, 2015-2016 Through 2019-2020. Clin Infect Dis. 2023 02 08; 76(3):e1031-e1039.
    View in: PubMed
    Score: 0.049
  49. Diversity and evolution of computationally predicted T cell epitopes against human respiratory syncytial virus. PLoS Comput Biol. 2023 01; 19(1):e1010360.
    View in: PubMed
    Score: 0.048
  50. Abnormalities in cardiac and inflammatory biomarkers in ambulatory subjects after COVID-19 infection. Int J Cardiol Heart Vasc. 2022 Dec; 43:101144.
    View in: PubMed
    Score: 0.048
  51. Comparative analysis of three multiplex platforms for the detection of respiratory viral pathogens. J Clin Virol. 2022 11; 156:105274.
    View in: PubMed
    Score: 0.047
  52. Whole lung lavage: Treating pulmonary alveolar proteinosis at the time of COVID pandemic. Respir Med Case Rep. 2022; 39:101707.
    View in: PubMed
    Score: 0.047
  53. Multiple Respiratory Syncytial Virus (RSV) Strains Infecting HEp-2 and A549 Cells Reveal Cell Line-Dependent Differences in Resistance to RSV Infection. J Virol. 2022 04 13; 96(7):e0190421.
    View in: PubMed
    Score: 0.046
  54. Respiratory Viral Infections and Infection Prevention Practices Among Women With Acute Respiratory Illness During Delivery Hospitalizations During the 2019-2020 Influenza Season. J Infect Dis. 2022 01 05; 225(1):50-54.
    View in: PubMed
    Score: 0.045
  55. Novel and extendable genotyping system for human respiratory syncytial virus based on whole-genome sequence analysis. Influenza Other Respir Viruses. 2022 05; 16(3):492-500.
    View in: PubMed
    Score: 0.045
  56. Transmission event of SARS-CoV-2 delta variant reveals multiple vaccine breakthrough infections. BMC Med. 2021 10 01; 19(1):255.
    View in: PubMed
    Score: 0.044
  57. Comparison of Mid-Turbinate and Nasopharyngeal Specimens for Molecular Detection of SARS-CoV-2 Among Symptomatic Outpatients at a Pediatric Drive-Through Testing Site. J Pediatric Infect Dis Soc. 2021 Sep 23; 10(8):872-879.
    View in: PubMed
    Score: 0.044
  58. Oligonucleotide capture sequencing of the SARS-CoV-2 genome and subgenomic fragments from COVID-19 individuals. PLoS One. 2021; 16(8):e0244468.
    View in: PubMed
    Score: 0.044
  59. The human nose organoid respiratory virus model: an ex-vivo human challenge model to study RSV and SARS-CoV-2 pathogenesis and evaluate therapeutics. bioRxiv. 2021 Jul 28.
    View in: PubMed
    Score: 0.044
  60. Proposal for Human Respiratory Syncytial Virus Nomenclature below the Species Level. Emerg Infect Dis. 2021 06; 27(6):1-9.
    View in: PubMed
    Score: 0.043
  61. Evaluating recovery, cost, and throughput of different concentration methods for SARS-CoV-2 wastewater-based epidemiology. Water Res. 2021 Jun 01; 197:117043.
    View in: PubMed
    Score: 0.043
  62. The Human Nose Organoid Respiratory Virus Model: an Ex Vivo Human Challenge Model To Study Respiratory Syncytial Virus (RSV) and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Pathogenesis and Evaluate Therapeutics. mBio. 2021 02 22; 13(1):e0351121.
    View in: PubMed
    Score: 0.042
  63. Detection of Respiratory Syncytial Virus or Rhinovirus Weeks After Hospitalization for Bronchiolitis and the Risk of Recurrent Wheezing. J Infect Dis. 2021 02 03; 223(2):268-277.
    View in: PubMed
    Score: 0.042
  64. Oligonucleotide Capture Sequencing of the SARS-CoV-2 Genome and Subgenomic Fragments from COVID-19 Individuals. bioRxiv. 2020 Dec 11.
    View in: PubMed
    Score: 0.042
  65. Oligonucleotide capture sequencing of the SARS-CoV-2 genome and subgenomic fragments from COVID-19 individuals. bioRxiv. 2020 Jul 27.
    View in: PubMed
    Score: 0.041
  66. Respiratory Syncytial Virus-Associated Hospitalizations Among Young Children: 2015-2016. Pediatrics. 2020 07; 146(1).
    View in: PubMed
    Score: 0.040
  67. Antigenic Fingerprinting of Respiratory Syncytial Virus (RSV)-A-Infected Hematopoietic Cell Transplant Recipients Reveals Importance of Mucosal Anti-RSV G Antibodies in Control of RSV Infection in Humans. J Infect Dis. 2020 02 03; 221(4):636-646.
    View in: PubMed
    Score: 0.039
  68. Non-gradient and genotype-dependent patterns of RSV gene expression. PLoS One. 2020; 15(1):e0227558.
    View in: PubMed
    Score: 0.039
  69. Duplex real-time RT-PCR assay for detection and subgroup-specific identification of human respiratory syncytial virus. J Virol Methods. 2019 09; 271:113676.
    View in: PubMed
    Score: 0.038
  70. Clinical characteristics and outcomes of respiratory syncytial virus infection in pregnant women. Vaccine. 2019 06 06; 37(26):3464-3471.
    View in: PubMed
    Score: 0.037
  71. Haemophilus-Dominant Nasopharyngeal Microbiota Is Associated With Delayed Clearance of Respiratory Syncytial Virus in Infants Hospitalized for Bronchiolitis. J Infect Dis. 2019 05 05; 219(11):1804-1808.
    View in: PubMed
    Score: 0.037
  72. Remote Laboratory Management: Respiratory Virus Diagnostics. J Vis Exp. 2019 04 06; (146).
    View in: PubMed
    Score: 0.037
  73. Genomic Loads and Genotypes of Respiratory Syncytial Virus: Viral Factors during Lower Respiratory Tract Infection in Chilean Hospitalized Infants. Int J Mol Sci. 2017 Mar 21; 18(3).
    View in: PubMed
    Score: 0.032
  74. The interdependencies of viral load, the innate immune response, and clinical outcome in children presenting to the emergency department with respiratory syncytial virus-associated bronchiolitis. PLoS One. 2017; 12(3):e0172953.
    View in: PubMed
    Score: 0.032
  75. Influenza Vaccine Effectiveness Against 2009 Pandemic Influenza A(H1N1) Virus Differed by Vaccine Type During 2013-2014 in the United States. J Infect Dis. 2016 May 15; 213(10):1546-56.
    View in: PubMed
    Score: 0.030
  76. Detection of respiratory syncytial virus and rhinovirus in healthy infants. BMC Res Notes. 2015 Nov 25; 8:718.
    View in: PubMed
    Score: 0.029
  77. Factors associated with real-time RT-PCR cycle threshold values among medically attended influenza episodes. J Med Virol. 2016 Apr; 88(4):719-23.
    View in: PubMed
    Score: 0.029
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.